GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Albert Labs International Corp (XCNQ:ABRT) » Definitions » EV-to-FCF

Albert Labs International (XCNQ:ABRT) EV-to-FCF : -1.53 (As of May. 27, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Albert Labs International EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Albert Labs International's Enterprise Value is C$0.75 Mil. Albert Labs International's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2023 was C$-0.49 Mil. Therefore, Albert Labs International's EV-to-FCF for today is -1.53.

The historical rank and industry rank for Albert Labs International's EV-to-FCF or its related term are showing as below:

XCNQ:ABRT' s EV-to-FCF Range Over the Past 10 Years
Min: -3.04   Med: 0   Max: 0
Current: -1.53

XCNQ:ABRT's EV-to-FCF is ranked worse than
100% of 369 companies
in the Biotechnology industry
Industry Median: 8.9 vs XCNQ:ABRT: -1.53

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-27), Albert Labs International's stock price is C$0.01. Albert Labs International's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 was C$-0.052. Therefore, Albert Labs International's PE Ratio for today is At Loss.


Albert Labs International EV-to-FCF Historical Data

The historical data trend for Albert Labs International's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Albert Labs International EV-to-FCF Chart

Albert Labs International Annual Data
Trend Dec21 Dec22
EV-to-FCF
- -1.77

Albert Labs International Quarterly Data
Mar21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.77 -1.77 -2.68 -5.61 -3.04

Competitive Comparison of Albert Labs International's EV-to-FCF

For the Biotechnology subindustry, Albert Labs International's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Albert Labs International's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Albert Labs International's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Albert Labs International's EV-to-FCF falls into.



Albert Labs International EV-to-FCF Calculation

Albert Labs International's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=0.754/-0.493
=-1.53

Albert Labs International's current Enterprise Value is C$0.75 Mil.
Albert Labs International's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.49 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Albert Labs International  (XCNQ:ABRT) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Albert Labs International's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.01/-0.052
=At Loss

Albert Labs International's share price for today is C$0.01.
Albert Labs International's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.052.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Albert Labs International EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Albert Labs International's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Albert Labs International (XCNQ:ABRT) Business Description

Traded in Other Exchanges
N/A
Address
6996, Merritt Avenue, Burnaby, BC, CAN, V5J 4R6
Albert Labs International Corp is a laboratory-based, clinical research and drug development enterprise addressing mental health care needs. The company is focusing on Real World Evidence (RWE) the company will initially look to commercialize its mycelium-based KRN-101 medicine and treatment with the help of clinical pathway.

Albert Labs International (XCNQ:ABRT) Headlines

No Headlines